Zavegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine

Cipolla, F; Capi, M; Lionetto, L; De Bernardini, D; De Angelis, V; Martelletti, P

Martelletti, P (corresponding author), Via Grottarossa 1035, I-00189 Rome, Italy.

DRUGS OF THE FUTURE, 2021; 46 (4): 281

Abstract

Zavegepant (BHV-3500, BMS-742413), under development by Biohaven Pharmaceuticals for the treatment of migraine, is a third-generation calcitonin gene-......

Full Text Link